Dianthus Therapeutics (DNTH) Insider Trading & Ownership $16.97 -0.89 (-4.98%) Closing price 04:00 PM EasternExtended Trading$25.70 +8.73 (+51.44%) As of 06:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Dianthus Therapeutics (NASDAQ:DNTH) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage16.56%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$1.31 MNumber OfInsiders Selling(Last 3 Years)0 Get DNTH Insider Trade Alerts Want to know when executives and insiders are buying or selling Dianthus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DNTH Insider Buying and Selling by Quarter Remove Ads Dianthus Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/29/2023Fairmount Funds Management LlcDirectorBuy24,670$13.63$336,252.10 9/26/2023Fairmount Funds Management LlcDirectorBuy30,000$13.15$394,500.00 9/21/2023Simrat RandhawaInsiderBuy2,000$13.20$26,400.00 9/19/2023Fairmount Funds Management LlcDirectorBuy30,000$13.20$396,000.00 9/12/2023Fairmount Funds Management LlcDirectorBuy14,887$10.85$161,523.95 (Data available from 1/1/2013 forward) DNTH Insider Trading Activity - Frequently Asked Questions Who is on Dianthus Therapeutics's Insider Roster? The list of insiders at Dianthus Therapeutics includes Fairmount Funds Management Llc, and Simrat Randhawa. Learn more on insiders at DNTH. What percentage of Dianthus Therapeutics stock is owned by insiders? 16.56% of Dianthus Therapeutics stock is owned by insiders. Learn more on DNTH's insider holdings. Which Dianthus Therapeutics insiders have been buying company stock? The following insiders have purchased DNTH shares in the last 24 months: Fairmount Funds Management Llc ($1,288,276.05), and Simrat Randhawa ($26,400.00). How much insider buying is happening at Dianthus Therapeutics? Insiders have purchased a total of 101,557 DNTH shares in the last 24 months for a total of $1,314,676.05 bought. Dianthus Therapeutics Key ExecutivesMr. Marino Garcia M.B.A. (Age 58)President, CEO, Secretary & Director Compensation: $496.02kMr. Ryan Savitz (Age 35)CFO and Chief Business Officer & Treasurer Compensation: $329.65kMr. Simrat Randhawa M.B.A. (Age 54)M.D., Chief Medical Officer Compensation: $338.16kMr. Edward G. Carr (Age 55)Chief Accounting Officer Mr. Judson TaylorHead of Technical OperationsDr. Jeffrey Stavenhagen Ph.D.Chief Scientific OfficerMs. Jennifer Davis RuffVP and Head of Investor Relations & Corporate Affairs.Mr. Adam M. Veness Esq. (Age 38)Senior VP, General Counsel & Secretary Ms. Kristina MaximenkoChief People OfficerMs. Rashieda GluckHead of Clinical Development Operations More Insider Trading Tools from MarketBeat Related Companies ImmunityBio Insider Trades Beam Therapeutics Insider Trades Vericel Insider Trades Mirum Pharmaceuticals Insider Trades Gemini Therapeutics Insider Trades Edgewise Therapeutics Insider Trades Centessa Pharmaceuticals Insider Trades Kymera Therapeutics Insider Trades CG Oncology Insider Trades Denali Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish This page (NASDAQ:DNTH) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredEU’s Action Takes Aim At US RetireesTrump's Return Sparks Massive Gold Rush—Is Your 401(k) Ready for the Fallout? With President Trump back and...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dianthus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dianthus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.